Practice parameters and technology assessments: what they are, what they are not, and why you should care.

A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology (2010) 1.38

Current and future treatment approaches for neuromyelitis optica. Ther Adv Neurol Disord (2011) 1.19

Evaluation of duration of epilepsy prior to temporal lobe epilepsy surgery during the past two decades. Epilepsy Res (2009) 0.92

A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis. BMC Neurol (2011) 0.87

A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis. Arch Neurol (2010) 0.79

Lost in a jungle of evidence: we need a compass. Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology (2009) 0.75

Neurogenic muscle cramps. J Neurol (2015) 0.75

History of Botulinum Toxin Treatment in Movement Disorders. Tremor Other Hyperkinet Mov (N Y) (2016) 0.75

Re: Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology (2009) 0.75

Lost in a jungle of evidence: we need a compass. Neurology (2009) 0.75

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain. Toxins (Basel) (2016) 0.75

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation. Toxins (Basel) (2015) 0.75

Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia (2010) 18.28

De novo mutations in epileptic encephalopathies. Nature (2013) 7.42

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia (2009) 7.03

Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia (2010) 5.64

The role of inflammation in epilepsy. Nat Rev Neurol (2010) 3.89

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia (2014) 1.97

Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol (2009) 1.73

Disparities in NIH funding for epilepsy research. Neurology (2011) 1.69

Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Epilepsia (2003) 1.66

Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol (2007) 1.44

Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics (2011) 1.36

The epilepsy phenome/genome project. Clin Trials (2013) 1.32

Remission and relapse in a drug-resistant epilepsy population followed prospectively. Epilepsia (2011) 1.14

Pregnancy registries: differences, similarities, and possible harmonization. Epilepsia (2010) 1.06

Who is helping whom? Manuscript support and transfer of value. Ann Neurol (2015) 1.06

Detection of epileptogenic cortical malformations with surface-based MRI morphometry. PLoS One (2011) 1.05

Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study. Epilepsia (2014) 0.98

Default mode network abnormalities in idiopathic generalized epilepsy. Epilepsy Behav (2012) 0.96

Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging (2011) 0.96

Therapeutic potential of new antiinflammatory drugs. Epilepsia (2011) 0.95

Perampanel for adjunctive treatment of partial-onset seizures: a pooled dose-response analysis of phase III studies. Epilepsia (2014) 0.91

Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav (2007) 0.85

Volume of the human septal forebrain region is a predictor of source memory accuracy. J Int Neuropsychol Soc (2011) 0.85

Individual differences in verbal abilities associated with regional blurring of the left gray and white matter boundary. J Neurosci (2011) 0.82

Septal nuclei enlargement in human temporal lobe epilepsy without mesial temporal sclerosis. Neurology (2013) 0.79

Cortical thickness abnormalities associated with depressive symptoms in temporal lobe epilepsy. Epilepsy Behav (2011) 0.79

Historical control withdrawal to monotherapy. Epilepsy Res (2006) 0.78

Antiepileptic drugs in development. Lancet Neurol (2006) 0.76

Author Response. Neurology (2015) 0.75

Consciousness in Focal Seizures: Either You're In or You're Out. Epilepsy Curr (2015) 0.75

Lamotrigine and aseptic meningitis. Neurology (2012) 0.75

Will Brivaracetam Help My Patient? Only Time Will Tell. Epilepsy Curr (2017) 0.75

To Our Readers and the AES Membership. Epilepsy Curr (2011) 0.75

A middle-aged man with severe asthma and newly diagnosed seizures. Epilepsy Behav (2003) 0.75

Management of patients with newly diagnosed epilepsy: a systematic literature review. Am Fam Physician (2004) 0.75